Biotech Values

[hptaxis]

Akebia Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
http://www.marketwatch.com/story/akebia-therapeutics-announces-closing-of-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-2015-04-22

CAMBRIDGE, Mass., Apr 22, 2015 (BUSINESS WIRE) -- Akebia Therapeutics, Inc. AKBA, -0.91% today announced the closing of its public offering of 8,363,636 shares of common stock at a public offering price of $8.25 per share. This includes the exercise in full by the underwriters of their option to purchase 1,090,909 shares of common stock. The aggregate net proceeds to Akebia, after underwriting discounts and commissions and estimated offering expenses, are approximately $64.6 million. All of the shares of common stock were offered by Akebia.